| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |